Adherence to Anticholinergic Therapy and Clean Intermittent Self-Catheterization in Patients With Multiple Sclerosis
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: To evaluate adherence to anticholinergic therapy (AT) and clean intermittent self-catheterization (CISC) in patients with multiple sclerosis (MS) and to identify factors associated with poor adherence. Methods: This single-center study prospectively included 49 patients suffering from MS who had been prescribed AT and/or CISC. Adherence was evaluated using a self-report questionnaire. The Expanded Disability Status Scale (EDSS), Patient Global Impression of Improvement, Mini-Mental State Examination, Urinary Symptom Profile, and Hospital Anxiety and Depression (HAD) instruments were administered, and the number of daily anticholinergic pills and/or catheterizations was noted. Whether patients were receiving concomitant intradetrusor botulinum toxin injections was assessed, as were barriers to treatment, side effects, number of spontaneous micturitions, reasons for the prescription, satisfaction, and difficulties. Results: Only 38% of patients were adherent to AT. Experiencing side effects was related to nonadherence (P=0.02). Only 29% of patients were adherent to CISC. More intense voiding dysfunction (P<0.001), a higher frequency of CISC (P=0.03), and a higher EDSS score (P=0.02) were associated with better adherence. Conversely, the HAD score (P<0.001), depression (P<0.001), the persistence of spontaneous micturition (P<0.001), a blocking sensation during catheterization (P=0.04), and the need to adapt one’s posture or gesture to perform catheterization (P=0.04) were associated with poorer adherence. Conclusions: Adherence to AT and CISC was poor in patients with MS suffering from bladder dysfunction. Several factors related to nonadherence were identified in this study, and addressing these factors might help to improve treatment adherence.
Abstract
Purpose: To evaluate adherence to anticholinergic therapy (AT) and clean intermittent self-catheterization (CISC) in patients with multiple sclerosis (MS) and to identify factors associated with poor adherence. Methods: This single-center study prospectively included 49 patients suffering from MS who had been prescribed AT and/or CISC. Adherence was evaluated using a self-report questionnaire. The Expanded Disability Status Scale (EDSS), Patient Global Impression of Improvement, Mini-Mental State Examination, Urinary Symptom Profile, and Hospital Anxiety and Depression (HAD) instruments were administered, and the number of daily anticholinergic pills and/or catheterizations was noted. Whether patients were receiving concomitant intradetrusor botulinum toxin injections was assessed, as were barriers to treatment, side effects, number of spontaneous micturitions, reasons for the prescription, satisfaction, and difficulties. Results: Only 38% of patients were adherent to AT. Experiencing side effects was related to nonadherence (P=0.02). Only 29% of patients were adherent to CISC. More intense voiding dysfunction (P<0.001), a higher frequency of CISC (P=0.03), and a higher EDSS score (P=0.02) were associated with better adherence. Conversely, the HAD score (P<0.001), depression (P<0.001), the persistence of spontaneous micturition (P<0.001), a blocking sensation during catheterization (P=0.04), and the need to adapt one’s posture or gesture to perform catheterization (P=0.04) were associated with poorer adherence. Conclusions: Adherence to AT and CISC was poor in patients with MS suffering from bladder dysfunction. Several factors related to nonadherence were identified in this study, and addressing these factors might help to improve treatment adherence.
참고문헌 (25)
- Jackevicius CA, "Adherence with statin therapy in elderly patients with and without acute coronary syndromes", JAMA, 288, pp.462~467 (2002)[DOI]
- Monane M, "The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly", Am J Hypertens, 10(7 Pt 1), pp.697~704 (1997)[DOI]
- DasGupta R, "Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies", Drugs, 63, pp.153~166 (2003)[DOI]
- Gomelsky A, "Update on the management of overactive bladder: patient considerations and adherence", Open Access J Urol, 3, pp.7~17 (2010)
- Sexton CC, "Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature", Int J Clin Pract, 65, pp.567~585 (2011)[DOI]
- Bolinger R, "Barriers, complications, adherence, and self-reported quality of life for people using clean intermittent catheterization", J Wound Ostomy Continence Nurs, 40, pp.83~89 (2013)[DOI]
- Morisky DE, "Predictive validity of a medication adherence measure in an outpatient setting", J Clin Hypertens (Greenwich), 10, pp.348~354 (2008)[DOI]
- Abrams P, "The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society", Neurourol Urodyn, 21, pp.167~178 (2002)[DOI]
- Yalcin I, "Validation of two global impression questionnaires for incontinence", Am J Obstet Gynecol, 189, pp.98~101 (2003)[DOI]
- Guinet-Lacoste A, "Validation of the InCaSaQ, a new tool for the evaluation of patient satisfaction with clean intermittent self-catheterization", Ann Phys Rehabil Med, 57, pp.159~168 (2014)[DOI]
- Guinet-Lacoste A, "Intermittent catheterization difficulty questionnaire (ICDQ): a new tool for the evaluation of patient difficulties with clean intermittent self-catheterization", Neurourol Urodyn, 35, pp.85~89 (2016)[DOI]
- Vrijens B, "Patient adherence to prescribed antimicrobial drug dosing regimens", J Antimicrob Chemother, 55, pp.616~627 (2005)[DOI]
- Gellad WF, "A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity", Am J Geriatr Pharmacother, 9, pp.11~23 (2011)[DOI]
- Barbosa CD, "A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence", Patient Prefer Adherence, 6, pp.39~48 (2012)
- Bruce JM, "Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition", J Behav Med, 33, pp.219~227 (2010)[DOI]
- Costello K, "Recognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term", Medscape J Med, 10, pp.225~ (2008)
- [URL]
- Appell RA, "The newer antimuscarinic drugs: bladder control with less dry mouth", Cleve Clin J Med, 69, pp.761~ (2002)
- Granger BB, "Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: doubleblind, randomised, controlled clinical trial", Lancet, 366, pp.2005~2011 (2005)[DOI]
- Balkrishnan R, "Predictors of medication adherence and associated health care costs in an older population with overactive bladder syndrome: a longitudinal cohort study", J Urol, 175(3 Pt 1), pp.1067~1071 (2006)[DOI]
- van Achterberg T, "Adherence to clean intermittent self-catheterization procedures: determinants explored", J Clin Nurs, 17, pp.394~402 (2008)
- Kessler TM, "Clean intermittent self-catheterization: a burden for the patient", Neurourol Urodyn, 28, pp.18~21 (2009)[DOI]
- Seth JH, "Ensuring patient adherence to clean intermittent self-catheterization", Patient Prefer Adherence, 8, pp.191~198 (2014)
- Amarenco G, "Pencil and paper test: a new tool to predict the ability of neurological patients to practice clean intermittent self-catheterization", J Urol, 185, pp.578~582 (2011)[DOI]
- Vahter L, "Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunction", Mult Scler, 15, pp.379~384 (2009)[DOI]